scispace - formally typeset
Open AccessJournal ArticleDOI

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Reads0
Chats0
TLDR
The prevention of HIV and TB, the extension of WHO DOTS programs, and a focused effort to control HIV-related TB in areas of high HIV prevalence are matters of great urgency.
Citations
More filters
Journal ArticleDOI

Projections of Global Mortality and Burden of Disease from 2002 to 2030

TL;DR: These projections represent a set of three visions of the future for population health, based on certain explicit assumptions, which enable us to appreciate better the implications for health and health policy of currently observed trends, and the likely impact of fairly certain future trends.
Journal ArticleDOI

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

TL;DR: A diarylquinoline, R207910, is identified that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro and mutants selected in vitro suggest that the drug targets the proton pump of adenosine triphosphate (ATP) synthase.
Journal ArticleDOI

IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge

TL;DR: It is proposed that vaccination induces IL-17-producing CD4+ T cells that populate the lung and, after challenge, trigger the production of chemokines that recruit CD4- T cells producing interferon-γ, which ultimately restrict bacterial growth.
Journal ArticleDOI

Host range and emerging and reemerging pathogens.

TL;DR: Emerging and reemerging species of human pathogens are associated with a broad range of nonhuman hosts and have the potential to pose a threat to human health.
Journal ArticleDOI

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.

TL;DR: Investment in new tools to improve diagnosis and treatment of those with LTBI at risk of progressing to disease is urgently needed to address this latent reservoir if the 2050 target of eliminating TB is to be reached.
References
More filters
Journal ArticleDOI

Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country

TL;DR: The global burden of tuberculosis remains enormous, mainly because of poor control in Southeast Asia, sub-Saharan Africa, and eastern Europe, and because of high rates of M tuberculosis and HIV coinfection in some African countries.
Journal ArticleDOI

A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection

TL;DR: The data suggest that in HIV-infected persons tuberculosis most often results from the reactivation of latent tuberculous infection; these results lend support to recommendations for the aggressive use of chemoprophylaxis against tuberculosis in patients with HIV infection and a positive PPD test.
Journal ArticleDOI

Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin

TL;DR: For patients with pulmonary tuberculosis that is resistant to rifampin and isoniazid, even the best available treatment is often unsuccessful, and only about half of such patients eventually have negative sputum cultures despite carefully selected regimens administered for extended periods.
Journal ArticleDOI

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

TL;DR: The survey conducted by the World Health Organization and the International Union against Tuberculosis and Lung Disease to assess trends in resistance to antituberculosis drugs in countries on six continents found that for patients with newly diagnosed tuberculosis, the frequency of resistance to at least one antituber tuberculosis drug ranged from 1.7 percent in Uruguay to 36.9 percent in Estonia.
Related Papers (5)